4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid

C56H52N4O19 — CID 101397474

IUPAC4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
SMILESO=C(NC1CCC(NC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)CC1)OC(C(=O)N1CCN(C(=O)c2cc3ccc(O)cc3oc2=O)CC1)c1ccc(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc1
InChIInChI=1S/C56H52N4O19/c61-26-44-46(65)47(66)48(67)55(78-44)75-35-12-2-27(3-13-35)49(52(70)60-19-17-59(18-20-60)51(69)40-21-28-1-9-32(62)23-41(28)77-54(40)73)79-56(74)58-31-7-5-30(6-8-31)57-50(68)29-4-14-36(53(71)72)39(22-29)45-37-15-10-33(63)24-42(37)76-43-25-34(64)11-16-38(43)45/h1-4,9-16,21-25,30-31,44,46-49,55,61-63,65-67H,5-8,17-20,26H2,(H,57,68)(H,58,74)(H,71,72)/t30?,31?,44-,46+,47+,48-,49?,55-/m1/s1
InChIKeyWKRPDLCLJVKILY-SGIUPVRUSA-N
MW1085.04 g/mol
LogP3.45
Rot. Bonds12

About 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid

4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid (PubChem CID 101397474) has the molecular formula C56H52N4O19 and a molecular weight of 1085.04 g/mol. Its IUPAC name is 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid.

Molecular Properties

Compound Name4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
PubChem CID101397474
Molecular FormulaC56H52N4O19
Molecular Weight1085.04 g/mol
Exact Mass1084.32
IUPAC Name4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
SMILESO=C(NC1CCC(NC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)CC1)OC(C(=O)N1CCN(C(=O)c2cc3ccc(O)cc3oc2=O)CC1)c1ccc(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc1
InChIInChI=1S/C56H52N4O19/c61-26-44-46(65)47(66)48(67)55(78-44)75-35-12-2-27(3-13-35)49(52(70)60-19-17-59(18-20-60)51(69)40-21-28-1-9-32(62)23-41(28)77-54(40)73)79-56(74)58-31-7-5-30(6-8-31)57-50(68)29-4-14-36(53(71)72)39(22-29)45-37-15-10-33(63)24-42(37)76-43-25-34(64)11-16-38(43)45/h1-4,9-16,21-25,30-31,44,46-49,55,61-63,65-67H,5-8,17-20,26H2,(H,57,68)(H,58,74)(H,71,72)/t30?,31?,44-,46+,47+,48-,49?,55-/m1/s1
InChIKeyWKRPDLCLJVKILY-SGIUPVRUSA-N
XLogP3.45
TPSA345.61 Ų
H-Bond Donors9
H-Bond Acceptors18
Rotatable Bonds12
Heavy Atoms79
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001085.04
LogP ≤ 53.45
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'cumarine', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid?
The IUPAC name of 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid (CID 101397474) is 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid.
What is the SMILES notation for 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid?
The canonical SMILES for 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid is O=C(NC1CCC(NC(=O)c2ccc(C(=O)O)c(-c3c4ccc(=O)cc-4oc4cc(O)ccc34)c2)CC1)OC(C(=O)N1CCN(C(=O)c2cc3ccc(O)cc3oc2=O)CC1)c1ccc(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc1.
What is the InChIKey of 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid?
The InChIKey is WKRPDLCLJVKILY-SGIUPVRUSA-N. The full InChI is InChI=1S/C56H52N4O19/c61-26-44-46(65)47(66)48(67)55(78-44)75-35-12-2-27(3-13-35)49(52(70)60-19-17-59(18-20-60)51(69)40-21-28-1-9-32(62)23-41(28)77-54(40)73)79-56(74)58-31-7-5-30(6-8-31)57-50(68)29-4-14-36(53(71)72)39(22-29)45-37-15-10-33(63)24-42(37)76-43-25-34(64)11-16-38(43)45/h1-4,9-16,21-25,30-31,44,46-49,55,61-63,65-67H,5-8,17-20,26H2,(H,57,68)(H,58,74)(H,71,72)/t30?,31?,44-,46+,47+,48-,49?,55-/m1/s1.
What are the key properties of 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid?
4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid has a molecular weight of 1085.04 g/mol, XLogP of 3.45, 12 rotatable bonds, 9 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[4-[[2-[4-(7-hydroxy-2-oxochromene-3-carbonyl)piperazin-1-yl]-2-oxo-1-[4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethoxy]carbonylamino]cyclohexyl]carbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid is sourced from PubChem (CID 101397474), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).